Los Angeles Capital Management LLC Kura Oncology, Inc. Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$24.75 - $39.14 $273,858 - $433,084	-11,065 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$29.0 - $41.62 $110,519 - $158,613	-3,811 Reduced 25.62%	11,065 $361,000
Q3 2020 Nov 02, 2020	SELL	$16.3 - $30.64 $1.1 Million - $2.06 Million	-67,314 Reduced 81.9%	14,876 $456,000
Q2 2020 Aug 05, 2020	BUY	$7.95 - $18.81 $264,854 - $626,655	33,315 Added 68.16%	82,190 $1.34 Million
Q1 2020 May 04, 2020	BUY	$6.45 - $14.04 $243,165 - $529,308	37,700 Added 337.36%	48,875 $486,000
Q4 2019 Feb 07, 2020	SELL	$12.97 - $15.94 $1,945 - $2,391	-150 Reduced 1.32%	11,175 $154,000
Q4 2018 Feb 11, 2019	SELL	$10.6 - $17.49 $1,325 - $2,186	-125 Reduced 1.09%	11,325 $159,000
Q3 2018 Nov 05, 2018	SELL	$16.65 - $21.85 $8,491 - $11,143	-510 Reduced 4.26%	11,450 $200,000
Q2 2018 Jul 31, 2018	BUY	$14.8 - $18.8 $177,008 - $224,848	11,960 New	11,960 $218,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.